| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |